Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Andrew, Gdowski"'
Autor:
Aryan Dalal, Sean Clark-Garvey, Andrew Gdowski, Sophia Zhang, Sara E. Wobker, Steven P. Rowe, Ersan Altun, Himisha Beltran, Matthew I. Milowsky
Publikováno v:
Case Reports in Oncological Medicine, Vol 2024 (2024)
Conclusion: This case illustrates the clinical presentation and highly aggressive nature of de novo NEPC. Recognizing atypical clinical progression in prostate cancer is critical for the detection of NEPC; however, despite early identification and in
Externí odkaz:
https://doaj.org/article/5db0e225d91345b3bd36186a9b5a584f
Autor:
Andrew Gdowski, Hamed Hayatshahi, Rafal Fudala, Rohan Joshi, Jin Liu, Jamboor K. Vishwanatha, Rohan Jeyarajah, Paul Guzik, Amalendu P. Ranjan
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 128 (2022)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies and is the fourth leading cause of cancer-related deaths in the United States. Unfortunately, 80–85% of patients are diagnosed with unresectable, advanced stage tumo
Externí odkaz:
https://doaj.org/article/d6f5db35a60d47868cc43803e8a15a02
Autor:
Andrew Gdowski, Kaitlyn Johnson, Sunil Shah, Ignacy Gryczynski, Jamboor Vishwanatha, Amalendu Ranjan
Publikováno v:
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. A
Externí odkaz:
https://doaj.org/article/b71d03dd42334f60bc7e0c5ecdcf4162
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3990-3995 (2015)
Treatments utilizing monoclonal antibody therapeutics against intracellular protein-protein interactions in cancer cells have been hampered by several factors, including poor intracellular uptake and rapid lysosomal degradation. Our current work exam
Externí odkaz:
https://doaj.org/article/66a394bed0324485b4ea7d8a5a170212
Autor:
Justin E. Bekelman, Debra Patt, Andrew Hertler, Ravi B. Parikh, Andrew Gdowski, Craig H. Mermel
Publikováno v:
American Society of Clinical Oncology Educational Book. :e53-e58
Big data and predictive analytics have immense potential to improve risk stratification, particularly in data-rich fields like oncology. This article reviews the literature published on use cases and challenges in applying predictive analytics to imp
Autor:
Holli Sadler, Andrew Gdowski, Doris Cubas, Christian Scherer, Alexandra Horton, Ye Aung, Nabeel Saghir
Publikováno v:
Journal of Clinical Oncology. 39:238-238
238 Background: Colon Cancer Screening is an important intervention to reduce the morbidity and mortality of colorectal cancer. In particular, stool based screening tests help to increase the availability of screening especially amidst a global pande
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-13 (2017)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Elucidation of mechanisms regulating bone metastasis has progressed significantly in recent years and this has translated to many new therapeutic options for patients with bone metastatic cancers. However, the rapid rate of progress in bot
Publikováno v:
World Journal of Surgery. 41:2854-2857
Chronic obstruction of the biliary system may cause hepatic fibrosis and liver failure. The purpose of this study was to define the incidence of unrecognized liver fibrosis in patients undergoing pancreaticoduodenectomy (PD). Retrospective data were
Autor:
Andrew Gdowski, Jamboor K. Vishwanatha, Anindita Mukerjee, Jana B. Lampe, Rohan P. Joshi, Victor Lin, Yu-Chieh Wang, Amalendu Prakash Ranjan
Publikováno v:
ACS Appl Nano Mater
Targeting therapeutic agents to specific organs in the body remains a challenge despite advances in the science of systemic drug delivery. We have engineered a programmable-bioinspired nanoparticle (P-BiNP) delivery system to simultaneously target th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d0cc376358f18c3d0499b18cf7507f
https://europepmc.org/articles/PMC7880042/
https://europepmc.org/articles/PMC7880042/
Autor:
Annie Bouchard, Amalendu Prakash Ranjan, Muhammed Majeed, Jamboor K. Vishwanatha, Andrew Gdowski, Anindita Mukerjee, Lawrence Helson
Publikováno v:
Journal of Biomedical Nanotechnology. 12:679-688
Non-small-cell lung cancer therapy is a challenge due to poor prognosis and low survival rate. There is an acute need for advanced therapies having higher drug efficacy, low immunogenicity and fewer side effects which will markedly improve patient co